Ixico FY revenues grow by more than a quarter
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.
Read moreMon, 13th Aug 2018 08:03
(Sharecast News) - AI data analytics company Ixico said on Monday that full-year revenues were up year-on-year as its data analytics service strategy continued to drive growth.
Read more(Sharecast News) - Data analytics company Ixico has entered into an agreement with NYU Langone Health to support a trial to determine if the immunosuppressant drug Sirolimus, approved by the FDA to prevent organ transplant rejection and for the treatment of a rare and progressive lung disease called lymphangioleiomyomatosis, is also able to slow the progression of disease in people with multiple system atrophy (MSA).
Read more(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).
Read more(Sharecast News) - Data analytics company Ixico has entered into a five-year collaboration with the Friedreich's Ataxia Research Alliance (FARA), it announced on Thursday, which it described as a non-profit organization dedicated to the pursuit of scientific research leading to treatments and a cure for Friedreich's Ataxia (FA).
Read more(Sharecast News) - Data analytics company Ixico has been selected by the Global Alzheimer's Platform Foundation (GAP) to support its planned 'Bio-Hermes' trial.
Read more(Sharecast News) - Data analytics company Ixico said on Monday that it had recorded "stronger-than-anticipated" second-half revenues and underlying earnings despite Covid-19.
Read more(Sharecast News) - Data analytics company Ixico said on Wednesday that Covid-19 had only had a "modest" impact on trading and stated it expects to maintain double-digit revenue growth in 2021.
Read more(Sharecast News) - Data analytics firm Ixico said on Monday that it was in a "robust" position to handle short-term headwinds stemming from the Covid-19 pandemic and associated government measures.
Read more(Sharecast News) - Neuroscience data analytics firm Ixico has inked a £10.5m contract for a late-phase open-label study into Huntington's disease, but warned that the Covid-19 pandemic had affected it in "multiple ways".
Read more(Sharecast News) - Artificial intelligence data analytics company Ixico announced funding support for the Alzheimer's Disease Neuroimaging Initiative (ADNI) on Monday, with two of its scientists to join the ADNI-Private Partner Scientific Board (PPSB).
Read more(Sharecast News) - Ixico revealed on Thursday that chief executive Giulio Cerroni had purchased 24,800 ordinary shares in the British clinical research firm.
Read more(Sharecast News) - Data analytics company Ixico announced a £1.8m extension to a phase 3 study in Huntington's Disease on Monday, which it had previously announced in September 2018.
Read more(Sharecast News) - AI data analytics company Ixico said on Monday that it had secured three new contracts and appointed a chief business officer.
Read more(Sharecast News) - Artificial intelligence data analytics company Ixico updated the market on its trading for the year ended 30 September on Tuesday, saying it expected its first full year of positive EBITDA since listing.
Read moreIXICO Predicts Maiden Positive Ebitda In Financial 2019
Read more